Zaltrap

Zaltrap (aflibercept) is a prescription medication used for certain types of cancer treatment. It works by blocking blood vessel growth in tumors. This overview covers key details for informational purposes only. Not intended for self-diagnosis or treatment decisions.

Zaltrap (aflibercept) is used in combination with other cancer therapies to treat metastatic colorectal cancer after certain prior treatments. It belongs to a class of drugs that target vascular endothelial growth factor (VEGF). Patients often ask what Zaltrap is used for in cancer care, as it helps slow tumor progression by reducing blood supply to cancerous tissue.

Zaltrap may help reduce tumor size or slow its growth when used as directed by a healthcare provider. Some patients experience changes in energy levels or appetite during treatment. Individual responses vary, and effects should be monitored by a medical professional throughout therapy.

Zaltrap is administered intravenously under medical supervision, typically in a clinical setting. Patients should discuss their full medical history with their doctor before starting treatment. Regular monitoring of blood pressure and blood tests is often recommended during therapy.

Zaltrap may interact with medications that affect blood clotting or blood pressure. Certain supplements or herbal products could also influence its effects. Patients should inform their healthcare provider about all medications and supplements they are taking before starting Zaltrap.